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trans activation of promoters by viral regulatory proteins provides a useful tool to study coordinate control
of gene expression. Immediate-early (IE) regions 1 and 2 of human cytomegalovirus (CMV) code for a series
of proteins that originate from differentially spliced mRNAs. These IE proteins are proposed to regulate the
temporal expression of the viral genome. To examine the structure and function of the IE proteins, we used
linker insertion mutagenesis of the IE gene region as well as cDNA expression vector cloning of the abundant
IE mRNAs. We showed that IEl and IE2 proteins of CMV exhibit promoter-specific differences in their modes
of action by either trans activating early and IE promoters or repressing the major IE promoter (MIEP).
Transient cotransfection experiments with permissive human cells revealed a synergistic interaction between
the 72- and the 86-kilodalton (kDa) IE proteins in trans activating an early promoter. In addition, transfection
studies revealed that the 72-kDa protein was capable of trans activating the MIEP. In contrast, the 86-kDa
protein specifically repressed the MIEP and this repression was suppressed by the 72-kDa protein. Further-
more, observations based on the primary sequence structure revealed a modular arrangement of putative
regulatory motifs that could either potentiate or repress gene expression. These modular domains are either
shared or unique among the IE proteins. From these data, we propose a model for IE protein function in the
coordinate control of CMV gene expression.
Infection of permissive human cells with human cytomeg-
alovirus (CMV) leads to an ordered sequential expression of
viral genes. The first genes expressed after infection are the
immediate-early (IE) genes, which require no prior viral
protein synthesis. The expression of IE proteins is required
for the initiation of early gene expression since infection in
the presence of protein synthesis inhibitors prevents subse-
quent viral gene expression (8, 26, 44, 45). Studies to date
have demonstrated that there are predominantly three dis-
tinct segments of the CMV genome expressed at IE times
(18, 21, 35, 37, 38, 40, 46). Originating from one of these
segments are two regions of abundant IE gene expression
designated IE region 1 (IE1) (37, 40) and IE region 2 (IE2)
(38, 40). These genes are transcribed from a single promoter
regulatory region, referred to as the major IE promoter
(MIEP), located upstream of IE1 (3, 38, 42). These two
regions code for a family of mRNAs that differ due to
splicing and which code for a series of unique but related
proteins (35, 38). IEI codes for the major IE protein which
originates from a 1.95-kilobase mRNA (37). IE2 codes for
several proteins, some of which share sequences with IEl
(35, 38). The predominant IE proteins from region 2 are the
86- and 55-kilodalton (kDa) proteins. The 55-kDa protein is
expressed only under IE conditions, while the 86-kDa pro-
tein persists throughout infection. At late times, a 40-kDa
protein is expressed from region 2 (35).
Numerous studies have shown that IE proteins function in
trans activation of promoters (7, 11, 16, 31, 41). However, all
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these studies dealt either with nonspecific heterologous viral
or cellular promoters or with transfection of cells nonper-
missive for CMV. In contrast, Staprans et al. (34) demon-
strated that a plasmid containing IEl and IE2 could activate
a CMV early promoter in human fibroblast cells. Also, a
recent study from our laboratory demonstrated that both IEl
and IE2 were necessary for activation of the CMV pp65
promoter (9). However, the role of specific IEl and IE2
proteins in activating viral gene expression was not ad-
dressed in these studies.
To better understand the regulatory role of the IE gene
products during infection, we investigated the ability of IEl
and IE2 insertion mutants and IE cDNA expression vectors
to activate CMV IE and early promoters in permissive cells.
Examination of the regulation of CMV promoters by these
wild-type and mutant proteins revealed common and unique
protein domains involved in activation and/or repression of
transcription. From the data presented in this study, we
propose a model for CMV gene activation by IE gene
products.
MATERIALS AND METHODS
Enzymes. Enzymes were obtained from New England
BioLabs, Inc. (Beverly, Mass.), Bethesda Research Labo-
ratories, Inc. (Gaithersburg, Md.), Boehringer Mannheim
Biochemicals (Indianapolis, Ind.), or Pharmacia LKB Bio-
technology (Piscataway, N.J.) and were used as recom-
mended by the supplier or according to standard protocols
described elsewhere (37, 38).
Recombinant plasmid DNAs. The plasmid pSVCC3 is
derived from pSVCC2 and has been described previously
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FIG. 1. (A) Structure of the IEl and IE2 expression vector pSVH. Exons representing IEl (1, 2, 3, and 4) and IE2 (1, 2, 3, 5, 6, and 7)
are indicated and as described previously (38). Sequence is numbered beginning at 40 nucleotides upstream of exon 1 (37). The construction
of pSVCC3, pAcc, and pSVH is as described in the Materials and Methods. The IE promoter (IE Pr) is indicated. (B) Structure of the DNA
polymerase gene and promoter fragment (15, 21). The polymerase promoter from EcoRI (E) to NsiI (N) was cloned into pSVOCAT and used
for transfection of HF cells. Map units showing the location of the pol gene and the relative location of the pol mRNA are indicated at the
bottom of the figure. kb, Kilobase.
(9). The plasmid pSVH (Fig. 1) was constructed by inserting
region 2 into the 3' end of pSVCC3 (9). The plasmid pAcc
was constructed by partial digestion of pSVH with AccI to
delete exon 4 of IE1 (9). The structures of pSVH, pSVCC3,
and pAcc are shown in Fig. 1A. pPolCAT (Fig. 1B) was
constructed by isolating the EcoRI-to-NsiI fragment contain-
ing the DNA polymerase promoter from pCMpol2b (15, 20).
HindIII linkers were added, and the fragment was cloned
into pSVOCAT. The plasmid pCAT760 was obtained from
M. Stinski and has been described previously (39). All
plasmids were grown and purified as described previously
(43).
Transfection and CAT assays. Transfections with IE plas-
mids (5 ,ug) and promoter-cat indicator plasmids (5 ,ug) were
done as previously described with human fibroblast (HF)
cells passaged 1:2 24 h earlier (9). Cells were harvested at 44
to 48 h after transfection and assayed for chloramphenicol
acetyltransferase (CAT) essentially as described previously
(9, 14). Assays were linear for 30 min for up to 50%
acetylation.
Mutational analysis. Linker insertion mutants were con-
structed as described in Fig. 2. The plasmid pSVH was
partially digested with either restriction enzyme FnuDII or
HaeIII as previously described (36). BamHI linkers (CGCG
GATCCGCG) (2 ,ug) were added to blunt-ended linear
molecules of pSVH (1 jig) in 20 p,l of ligase buffer (24) for 4
h at 15°C. The reaction mixture was subsequently diluted to
200 ,ul in 1 x ligase buffer and ligated overnight. The products
were transformed into Escherichia coli HB101 competent
cells and screened with restriction endonuclease BamHI.
After the linker insertion was mapped relative to the BamHI
site (located in the 3' end of IE1), mutants were tested for
their ability to regulate CMV promoters. Mutants that
showed phenotypic differences in trans activation were
redigested with BamHI, recloned to remove any multiple
linkers inserted during the initial cloning, and subsequently
retested for activity.
Western immunoblot analysis. To examine steady-state
levels of IE proteins, transfected HF cells were washed with
Tris-buffered saline (TBS) (30 mM Tris [pH 7.4], 150 mM
NaCl) and harvested in lysis buffer (50 mM Tris [pH 7.5], 1%
sodium dodecyl sulfate). Samples were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred to nitrocellulose as described previously (35).
Blots were reacted with a 1:1,000 dilution of antipeptide
antibody (8528) for 1 h at room temperature. Antipeptide
antibody 8528 recognizes amino acids 11 to 28 which are
common to TEl and IE2 proteins and has been described
previously (35). After extensive washings with TBS, blots
were reacted with a 1:1,000 dilution of horseradish peroxi-
dase-conjugated anti-rabbit immunoglobulin (Southern Bio-
technologies) and developed with horseradish peroxidase
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FIG. 2. Linker insertion mutagenesis of IEl and IE2. (A) pSVH was partially digested with FnuDII or HaeIII, and linear molecules were
isolated and ligated to BamHI linkers (12-mer, CGCGGATCCGCG). Mutants were generated as described in the Materials and Methods. (B)
Location of FnuDII and HaeIII sites (arrows) relative to IEl and IE2. Insertion mutants obtained and analyzed in this study are indicated
with a star.
developing reagent (Bio-Rad Laboratories, Richmond,
Calif.) as recommended by the supplier.
Construction of cDNA expression vectors. Synthesis of
cDNA to IE mRNAs was accomplished by a variation of the
method of Okayama and Berg (30). Briefly, an expression
vector was constructed that contains the large HindlIl-
to-EcoRI fragment of pcDVI and the small HindlIl-to-EcoRI
fragment of pLI ligated at their appropriate cohesive ends.
This vector, designated pSL, contains the simian virus 40
early promoter 5' to the KpnI site. Vector-primer DNA was
prepared exactly as described by Okayama and Berg (30)
and used to prime cDNA synthesis. IE cytoplasmic mRNA
was prepared as described previously (35, 37, 38). Approx-
imately 2 ptg of poly(A)-containing IE mRNA was mixed
with S ,ug of vector-primer in 25 IL of 50 mM Tris hydro-
chloride (pH 8.3)-75 mM KCl-5 mM MgCl2-10 mM dithio-
threitol-1 mM each dATP, dCTP, dGTP, and dTTP-500 U
of Moloney murine leukemia virus reverse transcriptase.
After 1 h at 37°C, the reaction was diluted sevenfold in 25
mM Tris hydrochloride (pH 8.3)-75 mM KCl-5 mM MgCl2-
250 ,LM dATP-250 ,uM dCTP-250 ,uM dGTP-250 F.M dTTP-
5 mM dithiothreitol-250 U of DNA polymerase I per ml-8.5
U of RNase H per ml. The second-strand reaction was
incubated at 16°C for 2 h, terminated with 10 mM EDTA,
and extracted with phenol-chloroform-isoamyl alcohol (25:
25:1). The vector-cDNA was precipitated with ethanol and
resuspended, and one-fifth of the product was ligated over-
night at 12°C under standard conditions. The ligation was
transformed into E. coli RR1 and plated on L agar containing
ampicillin.
Positive clones were selected by colony blot analysis
performed as described previously (24) and hybridized to
TEl- or IE2-specific probes previously described (35). Poten-
tial IE cDNA clones were subjected to Southern blot anal-
ysis and verified by hybridization to IE1 or IE2 probes.
cDNAs coding for the IE 72- and 55-kDa proteins were
isolated and constructed into a CMV expression vector as
described below. These cDNAs were judged "full length"
because they contained the SacIT site at +71 in exon 1 and
consequently were capable of coding for their complete
respective proteins. The 86-kDa cDNA was incomplete in
that it terminated in exon 2, 18 amino acids short of the
amino terminus. The restriction endonuclease pattern of this
cDNA was identical to that of the 55-kDa cDNA with
respect to sequences 5' to the IE2 donor splice site which
differentiates the 55- and 86-kDa mRNAs (35).
TEl and IE2 cDNAs were constructed into pSVCC3 and
pSVH, respectively, placing the sequences adjacent to their
appropriate promoter and 3' ends. For the TEl cDNA
(pIE72kd), construction employed the SacII site in exon 1
and the BamHI site in exon 4. For pIE55kd cDNA, the SacII
site in exon 1 and the Bsu36I site in the 3' end of IE2 were
utilized. To generate the pIE86kd expression vector, the
sequences between the SacII and Bsu36I sites in region 2
were excised from the 86-kDa cDNA and cloned into the
analogous sites in pIESSkd. This eliminates the spliced-out
region characteristic of the 55-kDa cDNA and effectively
constructs the 86-kDa cDNA.
RESULTS
Activation of pPolCAT by IE gene products. To examine
the role of IE proteins in activating CMV early gene expres-
sion, we cotransfected plasmids capable of expressing TEl
ATG
2
2
4i I
4
TAA ATG
I I
Hae iII
J. VIROL.
i
CMV IE PROTEIN FUNCTION 1559
TABLE 1. Activation by IE gene products'
% Acetylation % of nRelative
_______________ _______ pSVCC3 pSVCC3s +y
Expt + pAcc pSVCC3 +
pSVCC3 elative pAcc overpSVH pSVCC3 pAcc pSVCC3 relative either alone
+pAccto pSVH ~(fold)
1 8.9 0.7 0.5 5.6 63 8
2 12.6 1.1 1.1 6.2 49 6
3 8.4 0.7 0.6 4.9 54 7
4 6.7 0.7 0.7 4.3 64 6
Avg 9.1 0.8 0.7 5.3 58 7
a HF cells were transfected with 5 p.g of pPoICAT and 5 ,ug of the indicated
IE plasmids. In cotransfections with pSVCC3 plus pAcc, 2.5 pug of each
plasmid was used. The average of four experiments is indicated.
(pSVCC3), IE2 (pAcc), or both IEl and IE2 (pSVH) proteins
into HF cells with pPolCAT. In addition, IEl (pSVCC3) and
IE2 (pAcc) plasmids were transfected together with
pPolCAT in an attempt to reconstruct the effect of pSVH,
which expresses IEl and IE2 proteins. Preliminary studies
with pPolCAT demonstrated that the pol promoter functions
only in the appropriate orientation and that pol RNA initiates
from the correct 5' end (data not shown). Also, plasmid
vector pSVOd, which does not contain any CMV-specific
sequences, is unable to activate pPolCAT to a detectable
level (data not shown). The data from four experiments
demonstrated that IEl (pSVCC3)- and IE2 (pAcc)-specific
plasmids are unable to activate pPolCAT to significant
levels, although some level of expression consistently occurs
(Table 1). However, pSVH, which expresses both IEl and
IE2, activated the pol promoter to levels significantly higher
than IEl or IE2 alone (approximately 10-fold). Cotransfec-
tion of LEl (pSVCC3) and IE2 (pAcc) also resulted in
increased activation of pPolCAT, although at a slightly
reduced level when compared with pSVH (approximately
six- to eightfold). These data demonstrate that IE1 and IE2
gene products are necessary for complete activation of the
early DNA polymerase promoter.
Mutational analysis of IE gene region. To identify the
protein domains responsible for IE gene function, we con-
structed a series of linker insertion mutations within the IE
coding region. Figure 2 is a summary of the methodology
used to generate the mutants. Mutants were transfected into
HF cells in the presence of pPolCAT to compare the relative
level of trans activation with that ofpSVH. Initial analysis of
pPolCAT activation by the various mutants demonstrated
that regions within both IEl and IE2 are critical for early
promoter activation (Table 2). Within IE2, it appears that the
carboxy terminus is critical for early gene expression. Inser-
tion at amino acid 359 (ml3) or 540 (m14 and m15) resulted
in a significant reduction of activation of pPolCAT (approx-
imately six- to sevenfold). Mutations within the 5' half of
region 2 appeared to have no effect on activation ofpPolCAT
(amino acids 128 to 310).
Another mutation that affected function was located in
exon 3 of IEl at an HaeIII site (m2) at nucleotide 1275 (Table
2). This region was common to both IEl and IE2 and
disrupted several IE proteins (72, 86, and 55 kDa) at amino
acid 59. This resulted in an 80% inhibition relative to pSVH.
In addition, a second mutant (ml), located at amino acid 32,
caused a similar reduction in CAT activity. However, this
latter mutant was not recloned to remove excess linkers.
Also, we tested a number of IEl insertion (Table 2) and
deletion mutants, and all the mutants demonstrated a re-
TABLE 2. Effect of IE insertion mutants on promoter function'
Mutation
Target Effector (amino % of % of t
plasmid plasmid acid no.) pSVH pSVOd Acetylation
(IE protein)
pPolCAT pSVH 19
SVHml 32 (72/86) 23 4
SVHm2 59 (72/86) 21 4
SVHm3 128 (86) 84 16
SVHm4 146 (86) 88 16
SVHm5 150 (86) 67 13
SVHm6 154 (86) 81 15
SVHm7 167 (86) 132 25
SVHm8 216 (86) 91 17
SVHm9 252 (86) 90 17
SVHmlO 254 (86) 177 33
SVHmll 301 (86) 98 18
SVHm12 310 (86) 112 21
SVHm13 359 (86) 16 3
SVHm14 540 (86) 13 3
SVHm1S 540 (86) 11 2
pSVH 12
SVHm16 325 (72) 20 2
SVHm17 325 (72) 28 3
SVHm18 358 (72) 31 4
SVHm19 390 (72) 35 4
pCAT760 pSVOd 7
pSVH 194 13
pSVCC3 365 25
pAcc 32 2
SVHm2 59 (72/86) 96 7
SVHm3 128 (86) 162 11
SVHm4 146 (86) 151 10
SVHmS 150 (86) 135 9
SVHm6 154 (86) 226 16
SVHm7 167 (86) 135 9
SVHm8 252 (86) 184 13
SVHmll 301 (86) 113 8
SVHm12 310 (86) 293 20
SVHm13 359 (86) 1001 69
SVHm14 540 (86) 1001 69
aCAT values are expressed as percent acetylation. All mutants were tested
at least twice, and relative values were within experimental error. Numbers
presented are from a representative experiment.
duced ability to activate pPolCAT (R. M. Stenberg, unpub-
lished data).
Effect of IEl and IE2 mutants on IE promoter activity. We
next analyzed the effect of TEl and IE2 on IE promoter
activity. The plasmid pCAT760 was cotransfected into HF
cells with various IE insertion mutants, and the activity of
the IEl promoter was assessed. Table 2 demonstrates that
IEl (pSVCC3) stimulated pCAT760 almost fourfold, while
IE2 (pAcc) inhibited activity by 70%. IEl and IE2 together
resulted in a slight net increase (approximately twofold). The
various mutants had little effect with the exception of m13
and m14. These mutants failed to downregulate the promoter
and resulted in a greatly increased level of IE promoter
activation (approximately 10-fold relative to pSVH and
3-fold over that of TEl alone). The effect of the various IE
insertion mutants on activation and repression of CMV
promoter function is summarized in Fig. 3.
Analysis of proteins produced by IE mutants. To demon-
strate that the effect of the m13 and m14 mutations on
activation and repression was not due to an inability to
produce IE2 proteins, we analyzed the steady-state levels of
VOL. 64, 1990
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FIG. 3. Activation-repression by IE insertion mutants. The structure of the IE coding regions (thick black lines) and their corresponding
intervening sequences (thin black lines) are indicated at the top of the figure. The locations of the various mutants are indicated by the arrows.
The ability (+) or inability (-) of each mutant to activate the polymerase promoter or repress the MIEP is indicated. Activation of pPolCAT
and repression of pCAT760 are based on values obtained relative to pSVH. nd, Not done.
protein in transfected HF cells. Figure 4 clearly demon-
strates that all the IE2 mutants produced normal levels of IE
protein relative to pSVH except m13 and m14. These mu-
tants grossly overproduced all IE proteins including the 72-,
86-, and 55-kDa proteins as well as two minor IEl proteins of
38 and 31 kDa. In contrast, m2 underproduced the 72-kDa
protein, which may contribute to its decreased ability to
activate the polymerase promoter.
Expression of IE cDNAs in HF cells. To further analyze the
role of the IE proteins in regulating viral gene expression,
cDNAs capable of expressing individual IE proteins were
isolated and cloned into their appropriate IEl or IE2 vector.
'OI
Q. aQ 2 3 4 5 6 8 9 11121314
_ 86
__ ---- __ _ _ -72
-55
-38
-31
FIG. 4. Proteins expressed by IE insertion mutants. HF cells
were transfected with 10 p.g of the indicated plasmid, and cells were
harvested 48 h later. Samples were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and Western blot analy-
sis with antipeptide antibody 8528 (IE1-1). Protein molecular sizes
are expressed in kilodaltons on the right. Lane numbers indicate the
corresponding mutant.
The structures of the cDNAs and their vectors are shown in
Fig. 5A.
IE cDNAs were transfected into HF cells either alone or
in combination to test their ability to produce IE proteins.
The data in Fig. SB indicate that pIE55kd and pIE72kd
produced significant quantities of their respective proteins.
However, pIE86kd produced low to undetectable levels of
protein except in the presence of pIE72kd, when it produced
protein at significant levels. Also, in the presence of the
86-kDa protein, the level of the 72-kDa protein was reduced
when compared with transfection by pIE72kd alone. The
relative levels of the 72- and 86-kDa proteins in a mixed
transfection approximate the levels seen in a wild-type
infection (35).
Activation of pPolCAT by IE proteins. To determine the
IE2 proteins responsible for activation of pPolCAT, we
transfected the IE2 cDNAs either alone or in the presence of
pSVCC3, the IEl plasmid. Figure 6A demonstrates that IEl
(pSVCC3) and IE2 (pAcc) were necessary for activation of
the polymerase promoter. Cotransfection of pSVCC3 with
pIE86kd resulted in activation of pPolCAT to levels equiv-
alent to those of pAcc. In contrast, cotransfection of TEl
with pIE55kd did not result in a significant increase in
promoter activity. Individually, the IE cDNAs failed to
stimulate the polymerase promoter to significant levels.
To extend this study, we cotransfected pSVCC3 with
increasing quantities of either pAcc or pIE86kd. The data in
Fig. 6B indicate that pIE86kd and pAcc behaved identically
with respect to their ability to activate the polymerase
promoter.
DISCUSSION
Here we showed that the IE proteins of CMV exhibit
promoter-specific differences in their mode of action. The IE
proteins have the ability to trans activate early promoters
while trans repressing IE promoters. We identified impor-
J. VIROL.
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FIG. 5. Structure and expression of IE cDNAs. (A) Structure of IE mRNAs and the corresponding cDNAs. IE cDNAs were cloned 3' to
the IE promoter (IE Pr) and 5' to the appropriate IE 3' end. k, Kilodaltons. (B) Proteins expressed by IE cDNAs. HF cells were transfected
with a total of 10 ,ug of the indicated cDNAs, and extracts were prepared at 48 h. Samples were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and Western blot analysis with antipeptide antibody 8528 (IE1-1). Protein molecular sizes are
expressed in kilodaltons on the right. Lane M, Molecular size markers.
tant regions within these proteins involved in mediating
these effects. Furthermore, we cloned cDNA recombinants
corresponding to three of the most abundant IE proteins to
identify and evaluate critically the structure and function of
these IE proteins.
Activation of early promoters. Table 1 demonstrates that
the regulation ofCMV early gene expression, using the DNA
polymerase promoter as a model for activation, requires
both IE regions 1 and 2. As previously shown, this is also
true for the early-late pp65 phosphoprotein gene, which
behaves identically in similar assays (9). Consequently, this
may represent a common mechanism for early gene expres-
sion during a productive infection. Also, our use of cDNA
expression vectors demonstrated that within IE2 the 86-kDa
protein is responsible for this activation effect. These results
differ from earlier studies with heterologous promoters in
either HF (16) or Vero (31) cells which demonstrated that
IE2 was sufficient for trans activation of promoters. This
may be due to the contribution or interaction of cell-specific
factors with heterologous or non-CMV promoters. Also,
Chang et al. (4) demonstrated that IE2 could activate a CMV
early promoter. However, their data also demonstrated that
a plasmid containing both IEl and IE2 activated the CMV
early promoter approximately fourfold higher than IE2
alone. This is consistent with our studies (9; this report)
which demonstrate low levels of activation of early promot-
ers by IE2 but increased levels of activation by IEl and IE2.
Consequently, we conclude that IE1 and IE2 are synergistic
in their activation of CMV early promoters.
Activation and repression of MIEP. Earlier studies demon-
strated that the 72-kDa protein was capable of downregulat-
ing mRNA levels in nonpermissive COS cells and that an IEl
carboxy-terminal mutant was incapable of this effect (36).
Here, we extended those studies and found that IE2 gene
products are capable of repressing the activity of the MIEP
in permissive HF cells. Analysis of IE protein levels in cells
transfected with IE cDNAs indicated that the 86-kDa IE
protein is responsible for this effect. In addition, we demon-
strated that the IEl gene product is capable of stimulating
the MIEP in HF cells and that IEl and IE2 proteins together
resulted in little net change in expression when compared to
the MIEP alone. The finding that IEl can activate the MIEP
is consistent with the recent studies of Cherrington and
Mocarski (5). Also, MIEP activity varies in cells under
MTU=EMRMHIN I I I...........
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FIG. 6. (A) Activation of pPolCAT with IE cDNAs. HF cells
were cotransfected with pPolCAT and the indicated plasmids and
subsequently assayed for CAT. Open and closed bars represent the
results of duplicate experiments. (B) Activation of pPolCAT by
pAcc and pIE86kd. HF cells were transfected with pPolCAT (5 ,ug)
and increasing quantities of either pAcc (0) or pIE86kd (0).
Reactions were brought to 10 ,ug of total DNA by the addition of
pSVOd. CAT values are expressed as percent acetylation (% Ac).
permissive and nonpermissive conditions and this effect is
due to cell-specific proteins (29). Taken together, these
observations may implicate cell-specific components in me-
diating the function of the IE proteins. In particular, the
IE -1
72-kDa IE protein may behave as a trans activator of the
MIEP in permissive cells and as a repressor in nonpermis-
sive cells. The dominant ability of IEl protein(s) to negate or
suppress the negative effects of the IE2 proteins may have
biological significance in terms of their ability to regulate
CMV gene expression (see below).
Common and unique domains of IE proteins mediate acti-
vation and repression of expression. In an effort to identify the
domains responsible for IE protein function, a series of
linker insertion mutations were constructed. These muta-
tions were monitored for their ability to influence both IE
and early promoter activity. Three key regions were identi-
fied as important activation and/or repression domains. The
first resides within exon 3 between amino acids 32 and 59
(nucleotides 1194 to 1275) and appears to be specifically
required for the activation of the early promoter (Fig. 7).
This exon is leucine-rich, with a general motif of leucine-
X3-leucine. However, the significance of these leucine resi-
dues has yet to be resolved. In addition, the amino terminus
of the IE proteins contains a proline-rich region between
amino acids 11 and 25. Other nuclear transcription factors
have been shown to contain proline-rich regions (1, 2, 6, 22,
33), and a recent report by Mermod et al. (27) demonstrates
that the proline-rich region of CTF/NF1 corresponds to a
transcriptional activation domain.
A second potential domain resides within exon 4 and is
exclusive to the 72-kDa protein. An examination of the
primary sequence structure of this exon demonstrates that a
single putative zinc finger (17, 28, 32) is located in approxi-
mately the center of exon 4 (amino acids 266 to 285) (Fig. 7).
The importance of a single zinc finger in the 72-kDa protein
is not clear. Another sequence motif present in exon 4 is a
leucine zipper (23) which exists adjacent to the zinc finger
structure (amino acids 294 to 325) (Fig. 7). This motif
appears to promote protein-protein interactions to effect
DNA binding. Whether or not this region is capable of
forming a leucine zipper structure must await further exper-
imentation. Exon 4 also contains segments of polyglutamic
acid, which may form potential acidic activation domains, as
well as polyserine stretches, which form potential sites for
phosphorylation (13, 19, 47, 48). These homologies may
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is depicted. Direction of transcription from the promoters is indicated by the offset arrows. Arrows from the proteins indicate interaction of
the proteins and their subsequent influence on the promoters. The relative levels of activation (+) and repression (-) of the promoters by IE
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indicate that several distinct units exist within the protein
which interact with each other.
The third domain resides within IE region 2 between
amino acids 359 and 540 (nucleotides 3721 to 4262). These
sequences encompass a putative zinc finger distinct from
that present in the 72-kDa protein as well as a leucine-rich
domain which weakly conforms to a leucine zipper motif
(Fig. 7). This region serves as both an activator of the early
promoter and a repressor of the IE promoter. We could not
distinguish in the present study whether the activation and
repression domains are identical or overlap. However, it
does appear that the two mutants that define this domain are
phenotypically identical. Clearly, common and unique pro-
tein domains within the IE proteins are involved in mediating
activation and repression.
Finally, both proteins contain potential nuclear localiza-
tion signals which are characterized by the clustering of four
to six basic amino acids (10) as well as potential N-linked
glycosylation sites (25). The locations of the putative regu-
latory domains relative to the IE proteins are summarized in
Fig. 7.
Structure and function of 72-, 86-, and 55-kDa proteins. To
determine which IE2 proteins were responsible for activa-
tion and/or repression, we isolated cDNA clones corre-
sponding to the predominant IE proteins of 72, 86, and 55
kDa. An analysis of the structure of these clones confirmed
our previous observations on the splicing of the IE mRNAs
(35, 37, 38). Our studies clearly demonstrated that the
72-kDa protein plays a key role in the activation process.
Furthermore, this protein dominantly suppresses the repres-
sion effects of the IE2 proteins. The 86-kDa protein is
responsible for both the activation and repression effects on
the early pol promoter and the MIEP, respectively. Muta-
tions in the 86-kDa protein (m13 and m14) affect early
promoter activation and IE promoter repression and lead to
an increased level of all the IE proteins. The difference in
structure between the 55- and 86-kDa IE proteins lies within
the IE2 intron, which is an integral component of the 86-kDa
protein. This region contains the putative zinc finger and a
leucine-rich region (Fig. 7). This strongly associates these
regions with the activation-repression by the 86-kDa protein
and agrees with the mutagenesis study. These experiments
also clearly demonstrated the presence of multiple functional
domains within the IE gene region as well as multiple protein
involvement in regulating CMV gene expression.
Model for IE protein function. The differential effect of IE
proteins on IE and early gene expression in permissive and
nonpermissive cells may assist our understanding of the
potential mechanisms involved in latency. Negative regula-
tion of the IE promoter by TEl and IE2 gene products in
nonpermissive cells may (i) result in insufficient expression
of IE gene products necessary for the maintenance of the
replicative cycle or (ii) disrupt the balance of IE gene
products, resulting in improper activation of early and late
promoters. Our studies demonstrate that the 72- and 86-kDa
IE proteins interact to regulate subsequent CMV gene
expression (Fig. 8). While the 86-kDa IE protein is involved
in both activation and repression, it is clear that its expres-
sion is regulated by the presence of the 72-kDa IE protein.
This implies that the level of the 72-kDa protein produced in
the infected cell is the determining factor in the commitment
to activation or repression.
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